Aslı Sarandöl

1.3k total citations
52 papers, 989 citations indexed

About

Aslı Sarandöl is a scholar working on Psychiatry and Mental health, Clinical Psychology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Aslı Sarandöl has authored 52 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Aslı Sarandöl's work include Stress Responses and Cortisol (6 papers), Treatment of Major Depression (4 papers) and Art Therapy and Mental Health (3 papers). Aslı Sarandöl is often cited by papers focused on Stress Responses and Cortisol (6 papers), Treatment of Major Depression (4 papers) and Art Therapy and Mental Health (3 papers). Aslı Sarandöl collaborates with scholars based in Türkiye, Bosnia and Herzegovina and Saudi Arabia. Aslı Sarandöl's co-authors include Selçuk Kırlı, Emre Sarandöl, Salih Saygın Eker, Selda Erdinç, Ebru Vatansever, Cengiz Akkaya, Ayşen Esen-Danacı, Fatma Taneli, Şengül Cangür and Melahat Dirican and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Research and Journal of Psychiatric Research.

In The Last Decade

Aslı Sarandöl

47 papers receiving 952 citations

Peers

Aslı Sarandöl
Aslı Sarandöl
Citations per year, relative to Aslı Sarandöl Aslı Sarandöl (= 1×) peers Selçuk Kırlı

Countries citing papers authored by Aslı Sarandöl

Since Specialization
Citations

This map shows the geographic impact of Aslı Sarandöl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslı Sarandöl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslı Sarandöl more than expected).

Fields of papers citing papers by Aslı Sarandöl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aslı Sarandöl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslı Sarandöl. The network helps show where Aslı Sarandöl may publish in the future.

Co-authorship network of co-authors of Aslı Sarandöl

This figure shows the co-authorship network connecting the top 25 collaborators of Aslı Sarandöl. A scholar is included among the top collaborators of Aslı Sarandöl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslı Sarandöl. Aslı Sarandöl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarandöl, Emre, Aslı Sarandöl, Mesut Şener, Salih Saygın Eker, & Esma Sürmen-Gür. (2024). Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity. Human Psychopharmacology Clinical and Experimental. 39(6). e2913–e2913. 1 indexed citations
3.
Eker, Salih Saygın, et al.. (2022). ACUTE PSYCHOSIS FOLLOWING COVID-19 INFECTION: A CASE REPORT. Psychiatria Danubina. 34(1). 177–178. 2 indexed citations
4.
Aydın, Orkun, et al.. (2020). Examination of plasma zonulin levels in bipolar I disorder: a case–control study with follow-up. Journal of Neural Transmission. 127(10). 1419–1426. 4 indexed citations
5.
Yıldız, Mustafa, et al.. (2019). Rates and correlates of employment in patients with schizophrenia: A multicenter study in Turkey. International Journal of Social Psychiatry. 65(3). 235–243. 6 indexed citations
6.
Taşkapılıoğlu, Özlem, et al.. (2016). Psychopathology, Psychosocial Factors and Quality of Life in Patients with Myasthenia Gravis. 33(3). 482–493. 3 indexed citations
7.
Uzbay, Tayfun, Gökhan Göktalay, Hakan Kayır, et al.. (2013). Increased plasma agmatine levels in patients with schizophrenia. Journal of Psychiatric Research. 47(8). 1054–1060. 49 indexed citations
8.
Akkaya, Cengiz, et al.. (2011). The Effects of Reboxetine and Venlafaxine on ECG Variables in Depressed Patients. SHILAP Revista de lepidopterología. 21(1). 11–17. 1 indexed citations
9.
Oral, Haluk Barbaros, Kamıl Dilek, Özlem Taşkapılıoğlu, et al.. (2011). Interleukin‐4 Gene Polymorphisms Confer Behçet’s Disease in Turkish Population. Scandinavian Journal of Immunology. 73(6). 594–601. 14 indexed citations
10.
Sarandöl, Aslı, et al.. (2011). Androgens and sexual dysfunction in naturally and surgically menopausal women. Journal of obstetrics and gynaecology research. 37(8). 1027–1034. 12 indexed citations
11.
Dilek, Kamıl, Ümit Bingöl, Hayriye Sarıcaoğlu, et al.. (2011). IL-1 cluster gene polymorphisms in Turkish patients with Behçet’s disease. International Journal of Immunogenetics. 38(4). 295–301. 26 indexed citations
12.
Eker, Salih Saygın, Selçuk Kırlı, Cengiz Akkaya, Şengül Cangür, & Aslı Sarandöl. (2009). Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?. The World Journal of Biological Psychiatry. 10(4-2). 400–408. 6 indexed citations
13.
Akkaya, Cengiz, et al.. (2008). [Reliability and validity of the Turkish version of the Social Adaptation Self-Evaluation Scale (SASS)].. PubMed. 19(3). 292–9. 10 indexed citations
14.
Esen-Danacı, Ayşen, et al.. (2008). Effects of second generation antipsychotics on leptin and ghrelin. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(6). 1434–1438. 51 indexed citations
15.
Eker, Salih Saygın, Cengiz Akkaya, Aslı Sarandöl, et al.. (2008). Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(4). 955–961. 32 indexed citations
16.
Sarandöl, Aslı, et al.. (2007). Sociodemographic, disorder and treatment relatedcharacteristics affecting follow-up periods ofschizophrenic outpatients. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 17(1). 15–23. 1 indexed citations
17.
Sarandöl, Aslı, et al.. (2007). Oxidative–antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(6). 1164–1169. 78 indexed citations
18.
Akkaya, Cengiz, et al.. (2006). A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(8). 1535–1538. 13 indexed citations
19.
Sarandöl, Aslı, et al.. (2006). Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(6). 1103–1108. 55 indexed citations
20.
Sarandöl, Aslı, et al.. (2006). Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(2). 548–550. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026